Peptide-binding G protein-coupled receptors: new opportunities for drug design.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current Medicinal Chemistry

• Publication date

  2001-10-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/0929867013371798PMID 11562281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conformations of cyclic pentapeptide endothelin receptor antagonists.

  2009cited by this paper
• Cyclic hexapeptides related to somatostatin. Conformational analysis employing 1H-NMR and molecular dynamics.

  2009cited by this paper
• Structure of rhodopsin.

  2007cited by this paper
• Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

  1999cited by this paper
• Comprehensive survey of combinatorial library synthesis: 1998.

  1999cited by this paper
• Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity.

  1999cited by this paper
• Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivity.

  1999cited by this paper
• 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.

  1999cited by this paper
• In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16‐0335C, on guinea‐pig and rat kinin receptors

  1999cited by this paper
• Pharmacological treatment of obesity: therapeutic strategies.

  1999cited by this paper
• Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.

  1999cited by this paper
• Heart failure and endothelin receptor antagonists.

  1999cited by this paper
• Endothelin antagonists: substituted mesitylcarboxamides with high potency and selectivity for ET(A) receptors.

  1999cited by this paper
• Recent advances in neurokinin receptor antagonists.

  1999cited by this paper
• Butenolide endothelin antagonists with improved aqueous solubility.

  1999cited by this paper
• Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).

  1999cited by this paper
• A combinatorial approach toward the discovery of non-peptide, subtype-selective somatostatin receptor ligands.

  1999cited by this paper
• Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology.

  1999cited by this paper
• Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chain.

  1999cited by this paper
• Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.

  1999cited by this paper
• Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.

  1999cited by this paper
• Effects of the orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways.

  1999cited by this paper
• A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil.

  1999cited by this paper
• Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK(1) receptor antagonists: synthesis, antagonistic activity, and effects on bladder functions.

  1999cited by this paper
• Endothelin antagonism with bosentan: a review of potential applications

  1999cited by this paper
• Novel series of O-substituted 8-quinolines and 4-benzothiazoles as potent antagonists of the bradykinin B2 receptors.

  1999cited by this paper
• Molecular tinkering of G protein‐coupled receptors: an evolutionary success

  1999cited by this paper
• Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin.

  1998cited by this paper
• The Many Faces of G Protein Signaling*

  1998cited by this paper
• Effects of GR203040, an NK1 antagonist, on radiation- and cisplatin-induced tissue damage in the ferret.

  1998cited by this paper
• Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist.

  1998cited by this paper
• L-tryptophan urea amides as NK1/NK2 dual antagonists.

  1998cited by this paper
• Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.

  1998cited by this paper
• New goals for the U.S. Human Genome Project: 1998-2003.

  1998cited by this paper
• The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics.

  1998cited by this paper
• Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997

  1998cited by this paper
• High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template.

  1998cited by this paper
• Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists.

  1998cited by this paper
• The potency of the novel tachykinin receptor antagonist CGP49823 at rat and gerbil motoneurones in vitro.

  1998cited by this paper
• Endothelin: new discoveries and rapid progress in the clinic.

  1998cited by this paper
• Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin.

  1998cited by this paper
• Spiro-substituted piperidines as neurokinin receptor antagonists. II. Syntheses and NK2 receptor-antagonistic activities of N-[2-aryl-4-(spiro-substituted piperidin-1'-yl)butyl]carboxamides.

  1998cited by this paper
• G-Protein coupled receptors: models, mutagenesis, and drug design.

  1998cited by this paper
• A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.

  1998cited by this paper
• The substance P receptor antagonist CP‐99,994 reduces acute postoperative pain

  1998cited by this paper
• Effects of SR140333, a selective non‐peptide NK1 receptor antagonist, on trigemino‐thalamic nociceptive pathways in the rat

  1998cited by this paper
• Selective endothelin A receptor antagonists. 4. Discovery and structure-activity relationships of stilbene acid and alcohol derivatives.

  1998cited by this paper
• LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor

  1998cited by this paper
• A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.

  1998cited by this paper
• Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists.

  1998cited by this paper
• Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities.

  1998cited by this paper
• Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.

  1998cited by this paper
• A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.

  1998cited by this paper
• Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on guinea-pig tracheal smooth muscle bradykinin receptors.

  1998cited by this paper
• MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist

  1998cited by this paper
• Serine derived NK1 antagonists. 1: The effect of modifications to the serine substituents.

  1998cited by this paper
• Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist.

  1998cited by this paper
• Synthesis and NK1 receptor antagonistic activity of (+/-)-1-acyl-3-(3,4- dichlorophenyl)-3-[2-(spiro-substituted piperidin-1'-yl)ethyl]piperidines.

  1998cited by this paper
• Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

  1998cited by this paper
• A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.

  1998cited by this paper
• Neurobiology of the Caenorhabditis elegans genome.

  1998cited by this paper
• Serine derived NK1 antagonists. 2: A pharmacophore model for arylsulfonamide binding.

  1998cited by this paper
• Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives.

  1998cited by this paper
• Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor.

  1998cited by this paper
• GPCRDB: an information system for G protein-coupled receptors

  1998cited by this paper
• The dual nature of the tachykinin NK1 receptor.

  1997cited by this paper
• Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist.

  1997cited by this paper
• Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.

  1997cited by this paper
• How receptors talk to trimeric G proteins.

  1997cited by this paper
• Essential role of growth hormone in ischemia-induced retinal neovascularization.

  1997cited by this paper
• Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy.

  1997cited by this paper
• Neuropeptide Y family of hormones: receptor subtypes and antagonists.

  1997cited by this paper
• Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs.

  1997cited by this paper
• Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.

  1997cited by this paper
• Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis

  1997cited by this paper
• Clinical development of endothelin receptor antagonists.

  1997cited by this paper
• Arrangement of rhodopsin transmembrane alpha-helices.

  1997cited by this paper
• FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.

  1997cited by this paper
• Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.

  1997cited by this paper
• Potent, long-acting bradykinin antagonists for a wide range of applications.

  1997cited by this paper
• An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.

  1997cited by this paper
• Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery.

  1997cited by this paper
• Inhibitors of endothelin

  1997cited by this paper
• G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition

  1997cited by this paper
• Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy.

  1997cited by this paper
• A refined model for the somatostatin pharmacophore: conformational analysis of lanthionine-sandostatin analogs.

  1997cited by this paper
• Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists.

  1997cited by this paper
• The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657

  1997cited by this paper
• Nonpeptide antagonists of the NK1 tachykinin receptor

  1996cited by this paper
• A receptor subtype involved in neuropeptide-Y-induced food intake

  1996cited by this paper
• Rationally designed non-peptides: Variously substituted piperazine libraries for the discovery of bradykinin antagonists and other G-protein-coupled receptor ligands

  1996cited by this paper
• 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists.

  1996cited by this paper
• Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.

  1996cited by this paper
• 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.

  1996cited by this paper
• Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.

  1996cited by this paper
• Mechanistic hypotheses for the activation of G-protein-coupled receptors.

  1996cited by this paper
• Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.

  1996cited by this paper
• Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist.

  1996cited by this paper
• Projection structure of an invertebrate rhodopsin.

  1996cited by this paper
• Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.

  1996cited by this paper

• Single-cell transcriptomic evidence for dense intracortical neuropeptide networks

  2019cites this paper
• Transcriptomic evidence for dense peptidergic neuromodulation networks in mouse cortex

  2019cites this paper
• Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.

  2018cites this paper
• Structural effects of extracellular loop mutations in CFTR helical hairpins.

  2018cites this paper
• Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma

  2017cites this paper
• A Synaptic Basis for GLP-1 Action in the Brain.

  2017cites this paper
• Theoretical Engineering of the Gut Micro biome for the Purpose of Creating Superior Soldiers

  2017cites this paper
• Importancia de la sustancia P y su receptor NK-1R en el cáncer de tiroides

  2016cites this paper
• Room Temperature Synthesis and Antibacterial Activity of New Sulfonamides Containing N,N -Diethyl-Substituted

  2014cites this paper
• Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent

  2013cites this paper
• Design, Synthesis, and Evaluation of Functionalized Chroman-4-one and Chromone Derivatives. Somatostatin receptor agonists and Sirt2 inhibitors

  2012cites this paper
• Contemporary methods in structure determination of membrane proteins by solution NMR.

  2012cites this paper
• Magic angle spinning NMR study of interaction of N-terminal sequence of dermorphin (Tyr-d-Ala-Phe-Gly) with phospholipids.

  2012cites this paper
• Room Temperature Synthesis and Antibacterial Activity of New Sulfonamides Containing N,N-Diethyl-Substituted Amido Moieties

  2012cites this paper
• MOLECULAR MECHANISM OF MICROTUBULE-SEVERING BY KATANIN P60

  2012cites this paper
• NMR of Proteins and Small Biomolecules

  2012influential citation
• Use of Somatostatin Analogues in Obesity

  2012cites this paper
• Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.

  2010cites this paper
• Nonpeptide ligands for peptidergic G protein-coupled receptors.

  2010cites this paper
• Identification of Residue-to-residue Contact between a Peptide Ligand and Its G Protein-coupled Receptor Using Periodate-mediated Dihydroxyphenylalanine Cross-linking and Mass Spectrometry*

  2010cites this paper
• Neuropeptide signaling in insects.

  2010cites this paper
• Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.

  2009cites this paper
• New insights into GPCR function: implications for HTS.

  2009cites this paper
• “Saccharomyces cerevisiae G protein Coupled Receptor, Ste2p Interactions with its Ligand, α-factor and Cognate Gα protein, Gpa1p

  2009influential citation
• Maraviroc Discovery and Resistance: Current Understanding and Future Considerations

  2008cites this paper
• N-methylation of peptides: a new perspective in medicinal chemistry.

  2008cites this paper
• Structural insight on the activity of type 1 angiotensin II peptide antagonists using MD simulations.

  2008cites this paper
• Effects of beta‐cell rest on beta‐cell function: a review of clinical and preclinical data

  2008cites this paper
• Stable interactions between the transmembrane domains of the adenosine A2A receptor

  2008cites this paper
• Molecular Modeling of Vasopressin V2 Receptor Tetramer in Hydrated Lipid Membrane

  2008cites this paper
• A Link Means a Lot : Disulfide Tethering in Structure-Based Drug Design

  2007cites this paper
• cDNA-Derived Amino Acid Sequence from Rat Brain A2aR Possesses Conserved Motifs PMNYM of TM 5 Domain, Which May Be Involved in Dimerization of A2aR

  2007cites this paper
• Cytokines in Human Health

  2007cites this paper
• Use of adenoviruses to study isoform specificity of G-protein-receptor-coupled Ca2+ signaling in intact epithelial cells

  2007cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• Emerging Concepts of Guanine Nucleotide-Binding Protein-Coupled Receptor (GPCR) Function and Implications for High Throughput Screening

  2007cites this paper
• Peptides as transmembrane segments: decrypting the determinants for helix-helix interactions in membrane proteins.

  2007cites this paper
• Nonpeptidic ligands for peptide-activated G protein-coupled receptors.

  2007cites this paper
• Role of the extracellular loop in the folding of a CFTR transmembrane helical hairpin.

  2007cites this paper
• Design and synthesis of small nonpeptidergic ligands for the human cytomegalovirus-encoded receptor US28

  2007cites this paper
• Microbial Exploitation and Subversion of the Human Chemokine Network

  2007cites this paper
• Synthesis of β-turn and pyridine based peptidomimetics

  2007cites this paper
• Chapter 17:A Link Means a Lot: Disulfide Tethering in Structure-Based Drug Design

  2007cites this paper
• 7TM Receptors

  2007cites this paper
• Création et utilisation de chimiothèques optimisées pour la recherche in silico de nouveaux composés bioactifs

  2006cites this paper
• Development of binding and functional assays for the neuropeptide Y Y 2 and Y 4 receptors

  2006influential citation
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir

  2006cites this paper
• Synthesis and biological evaluation of leucine enkephalin turn mimetics.

  2006cites this paper
• Anaphylatoxin and chemotactic peptide

  2006cites this paper
• 7 TM RECEPTORS

  2006cites this paper
• G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation.

  2005cites this paper
• Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.

  2005cites this paper
• Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.

  2005cites this paper
• Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry.

  2005cites this paper
• Nonpeptide ligands that target peptide-activated GPCRs in inflammation.

  2005cites this paper
• CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection

  2005cites this paper
• Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.

  2005cites this paper
• Site-specific Disulfide Capture of Agonist and Antagonist Peptides on the C5a Receptor*

  2005cites this paper
• Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor

  2005cites this paper
• Identifying interactions between transmembrane helices from the adenosine A2A receptor.

  2005cites this paper
• Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders.

  2004cites this paper
• Tools for anti‐inflammatory drug design: In vitro models of leukocyte migration

  2004cites this paper
• Tachykinins and tachykinin receptors: structure and activity relationships.

  2004cites this paper
• The alpha-factor mating pheromone of Saccharomyces cerevisiae: a model for studying the interaction of peptide hormones and G protein-coupled receptors.

  2004cites this paper
• EFFECTS OF ESTROGEN ON THE EXPRESSION OF GPR41 AS DETECTED BY A NOVEL ANTIBODY

  2004cites this paper
• Missense mutations in transmembrane domains of proteins: Phenotypic propensity of polar residues for human disease

  2004cites this paper
• Characterization of peptides corresponding to the seven transmembrane domains of human adenosine A2a receptor.

  2004cites this paper
• Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.

  2004cites this paper
• The α-factor mating pheromone of Saccharomyces cerevisiae: a model for studying the interaction of peptide hormones and G protein-coupled receptors

  2004cites this paper
• Guide to Receptors and Channels, 1st Edition

  2004cites this paper
• Polar residue tagging of transmembrane peptides.

  2003cites this paper
• RGS6, RGS7, RGS9, and RGS11 Stimulate GTPase Activity of Gi Family G-proteins with Differential Selectivity and Maximal Activity*

  2003cites this paper
• Generation of a bioactive neuropeptide in a cell-free system.

  2003cites this paper
• Recent developments in the medicinal chemistry of NK2 receptor antagonists.

  2003cites this paper
• Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors.

  2003cites this paper
• Arrestin Variants Display Differential Binding Characteristics for the Phosphorylated N-Formyl Peptide Receptor Carboxyl Terminus*

  2002cites this paper
• Tyr266 in the sixth transmembrane domain of the yeast alpha-factor receptor plays key roles in receptor activation and ligand specificity.

  2002cites this paper
• [The race for a new target. The human AT1 receptor].

  2001cites this paper
• Drug design--chemistry and biology.

  2001cites this paper
• Der humane AT1‐Rezeptor: Wettlauf um ein neues Target

  2001cites this paper